1,334
Participants
Start Date
May 31, 2015
Primary Completion Date
April 30, 2017
Study Completion Date
March 31, 2021
Orsiro DES
Orsiro is a device/drug combination product composed of two components, a device (coronary stent system including a cobalt chromium stent platform), and a drug product (a formulation of sirolimus) contained in a bioabsorbable polymer coating.
Xience DES
Lausanne
Budapest
Auckland
Leuven
Genk
Szeged
Pécs
Zurich
Zurich
Aarhus
Roeselare
New York
New York
New York
Berlin
Berlin
Butler
Mechanicsburg
York
Wynnewood
Washington D.C.
Hamburg
Baltimore
Charlottesville
Virginia Beach
Bad Segeberg
Charleston
Greensboro
Madrid
Asheville
Málaga
Greenville
Rock Hill
Atlanta
Haifa
Minden
Orlando
Hollywood
Tampa
Clearwater
Fairhope
Knoxville
Seville
Neuss
Columbus
Toledo
Toledo
Elyria
Cleveland
Cincinnati
Fort Wayne
Troy
Ypsilanti
Detroit
Rochester
Pontiac
Bay City
Lansing
Petah Tikva
Minneapolis
Fargo
Urbana
Tel Aviv
Omaha
McKinney
Dallas
Tyler
Rehovot
Houston
Jerusalem
La Mesa
Laguna Hills
Mission Viejo
Concord
Portland
Boston
Hackensack
Neptune City
Newark
Providence
Adelaide
Calgary
Breda
Eindhoven
Nieuwegein
Daegu
Gwangju
Seoul
Seoul
Seoul
Barcelona
Barcelona
Lead Sponsor
Biotronik AG
INDUSTRY
Baim Institute for Clinical Research
OTHER
Medstar Health Research Institute
OTHER
Biotronik, Inc.
INDUSTRY